11th World Congress on

Clinical Microbiology & Infectious Diseases

Theme: Importance of Addressing the Microbial Complexity of Infectious Diseases

Event Date & Time

Event Location

Sydney, Australia

18 years of lifescience communication

442838022009

Performers / Professionals From Around The Globe

Tracks & Key Topics

11th Infectious Diseases 2019

About Conference

We cordially invite you all the participants from all over the world to attend ‘Infectious diseases conference 2019’ which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.

Microbial Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles(1 Million), HIV/AIDS(1 Million), Hepatitis B (1.1 Million), Malaria (2.1 Million), Diarrhoea (3.1 Million), Tuberculosis (3.1 Million), Respiratory Infections (4.4 Million).

Who should attend?

Microbiologists

Bacteriologists

Virologists

Parasitologists

Mycologists

Pathologists

Pharmacists

Epidemiologists

Dermatologists

Neurologist

Ophthalmologist

Cardiologist

Health Care Professionals

Why to attend?

With members from around the world focused on teach Importance of Addressing the microbial Complexity of Infectious Diseases and its advances in therapeutic and diagnostic market; this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2 day event. World’s eminent speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

 Targeted Audience

 Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments

Infectious Diseases Researchers, Scientists, Faculties, Students

Infectious Diseases Associations and Societies

Medical Colleges

Pharmaceutical Companies and Industries

Medical Devices Manufacturing Companies

Drug Manufacturing Companies and Industries

Laboratory Technicians and Diagnostic Companies

Business Entrepreneurs and Industrialists

Training Institutes

Software Developing Companies

Data Management Companies

For Scientific Sessions please go through the link: 

https://infectiousdiseasesconference.euroscicon.com/call-for-abstracts

For Abstract Submission please go through the link:

https://infectiousdiseasesconference.euroscicon.com/abstrcat-submission

 

Session Tracks

Applied & Medical Microbiology

The study of microbial world and the way it interacts with our own. It looks how we can harness and utilize the powers of the microbes in areas ranging from biotechnology to pest control, to bio-refineries, to pharmaceutical applications. A wide range of microbial bio products is possible. Restorative microbiology is a part of medication managing the counteractive action, finding and treatment of irresistible and additionally non-irresistible ailments. Therapeutic microbiologists manage clinical interviews on the examination, standards of finding, treatment, and counteractive action of irresistible maladies; the logical advancement, regulatory and medicinal course of a clinical microbiology research facility; the foundation and bearing of contamination control programs over the continuum of consideration; transferable sickness aversion and the study of disease transmission and related general medical problems.

 

Chemotherapy

Chemotherapy is a form of chemical drug therapy meant to destroy rapidly growing cells in the body. It is usually used to treat cancer, as cancer cells grow and divide faster than other cells. This is often used in combination with other therapies, such as surgery, radiation, or hormone therapy. This depends on the stage and type of cancer and location of the cancer cells

Clinical and Diagnostic Microbiology

Clinical biology considers microbiological aspects of human and animal infection by pathogens like microorganism, viruses, fungi and protozoa. Common topics of interest to clinical biology embrace the character of the etiologic agents, their interactions with the system, and therefore the diagnosing and medical specialty of communicable disease.

Clinical Immunology

Diseases caused by disorders of the immune system (failure, aberrant action, and malignant growth of the cellular elements of the system). It also involves diseases of other systems, where immune reactions play an part in the pathology and clinical features. The diseases caused by disorders of the immune system categorized into two broad categories:

Immunodeficiency: in which parts of the immune system fail to provide an adequate response (examples: chronic granulomatous disease and primary immune diseases).

Autoimmunity: in which the immune system attacks its own host's body (examples: systemic lupus erythematous, rheumatoid arthritis, Hashimoto's disease and myasthenia gravis).

Congenital, Perinatal and Neonatal Infections

Congenital diseases are the medical condition that is present at or before birth. These conditions also referred to as birth defects, can be acquired during the fatal stage of development or from the genetic makeup of the parents.  Neonatal infections are infections of the neonate acquired during prenatal development or in the first four weeks of life. Neonatal infections may be contracted by mother to child transmission, in the birth canal during childbirth, or after birth. Some neonatal infections are appear soon after delivery, while others may develop in the postnatal period. And other infections such as HIV, hepatitis B, and malaria do not become apparent until much later.

Cytopathology of infectious Diseases

Cytopathology provides a rapid, inexpensive, simple and effective mechanism to diagnose and manage a wide range of infectious diseases. A variety of ancillary techniques such as special stains, immunocytochemistry, and molecular studies can be applied to cytology samples, thereby increasing the specificity and sensitivity of microorganism including viruses, bacteria, fungi and parasites.

Epidemiology

The infectious disease and epidemiology encompasses domestic and global work on the emerging and re-emerging infections, global infectious disease threats, disease surveillance, disease detection, development of vaccines and other prevention methods. Clinical trials and the role of infectious pathogens in the pathogenesis of chronic non-communicable diseases such as cancer and cardiovascular disease. The broad range of novel pathogens using advanced molecular techniques to longitudinal population based studies to define transmission dynamics and spectrum of disease and survival. Approaches are utilized in an interdisciplinary fashion to define etiology, pathogenesis, transmission, and prevention/treatment potential.

Gastrointestinal Infections

These are viral, bacterial or parasitic infections that cause gastroenteritis, an inflammation of the gastrointestinal tract involving both the stomach and the small intestine. Symptoms include diarrhoea, vomiting, and abdominal pain. Dehydration is the main danger of gastrointestinal infections.

Haematological infections

Infectious diseases produce clinical or hematologic manifestations that simulate hematologic neoplasms, directly or indirectly cause anaemia or other abnormalities on peripheral blood counts, or they involve direct infection of hematopoietic or lymphoid tissues as specific targets of infections.

Hepatitis C

Hepatitis C is a disease that caused by inflammation and infection of the liver. This condition develops after infected with the hepatitis C virus (HCV). Hepatitis C can be either acute or chronic. hepatitis C don’t have symptoms but some people report mild to severe symptoms like fever, dark urine, loss of appetite, abdominal pain or discomfort, joint pain and jaundice.

Laboratory Techniques of Infectious Diseases

Laboratory tests are made to identify organisms directly (eg, visually, using a microscope, growing the organism in culture) or indirectly (eg, identifying antibodies to the organism). General types of tests include  a) Microscopy b) Culture  c) Immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, Western blot, precipitation tests, and complement fixation tests) d) Nucleic acid–based identification methods e) Non-nucleic acid–based identification methods

Microbial Pathogenesis

Microbial pathogens personify microorganism, viruses, fungi, and parasites and along account for a major proportion of acute and chronic human diseases. Additionally to understanding the mechanisms by that varied pathogens because human wellness, analysis in microbe pathological process additionally addresses mechanisms of antimicrobial resistance and also the development of latest antimicrobial agents and vaccines. It covers host-pathogen interaction and medicine associated with infectious agents, as well as microorganism, fungi, viruses and protozoa. Microbe pathological process is committed to the study of the genomic, molecular and cellular bases of clinical infectious diseases

Nosocomial Infections

A nosocomial disease is contracted in view of a contamination or poison that exists in a specific area, for example, a doctor's facility. Nosocomial Infections are one of the significant confusions for medicinal services experts to handle. Consistently they results in delayed doctor's facility stays, long haul handicap, and expanded obstruction of microorganisms to antimicrobials, extra expenses for medicinal services frameworks, high expenses for patients and their family, and pointless passing.

Parasitology

Parasitology is the study of parasites, their hosts, and the relationship between them. Every free-living species has its own unique species of parasite - humans included - such that the number of parasitic species greatly exceeds the number of free-living species. Parasites in humans result in millions of deaths each year throughout the world, but particularly in the developing world. Researchers in the Department are interested in studying the effects of parasites upon the human population, looking at the epidemiology of parasitic diseases such as malaria and sleeping sickness, the cellular mechanisms by which the parasite infects the host and causes disease, and the reaction of the immune system to the parasite.

Respiratory Infections

Respiratory tract infections refers to a number of infectious diseases involving the respiratory tract. An infection of this types are further classified as an Upper respiratory tract infection (URI or URTI) or a lower respiratory tract infection (LRI or LRTI). Lower respiratory infections are pneumonia, can cause more serious conditions than upper respiratory infections are the common cold.

Sexually Transmitted Infections

Sexually transmitted diseases are infections that pass from one person to another through sexual contact. Some STDs can spread through the use of unsterilized needles, from mother to infant during childbirth or breast-feeding and blood transfusions. The genital areas are generally moist and warm which are ideal for the growth of yeasts, viruses, and bacteria. Infected persons can transmit microorganisms that inhabit the skin or mucous membranes of the genitals. Infectious organisms can move between people in semen, vaginal secretions, or blood during sexual intercourse.

Surgical site Infections

Surgical site infections are the infection that occurs after surgery in the part of the body where the surgery took place. These infections can sometimes be superficial infections involving the skin only. Other surgical site infections are more serious, can involve tissues under the skin, organs, or implanted material. Some guidelines provides tools to the healthcare community to help end surgical site infections and resources to help the public understand these infections and take measures to safeguard their own health when possible.

Virology and Microbial agents

The science of microbiology deals with the structure, function, and classification of such organisms and with investigating as well as controlling their activities. One of the advantages of the science of microbiology is that it provides simple tools for studying basic life processes, since many cellular activities are shared by microbial cells

 

Market Analysis

The market size for clinical microbiology valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising of infectious diseases is driving market growth.
Infectious diseases are primarily diagnosed by using clinical tests. According to the Centres for Disease Control and Prevention (CDC), around 9,421 new cases of tuberculosis, 51,455 new cases of salmonella, 33,461 new cases of Lyme disease, and in 2014, 433 new cases of meningococcal disease were registered in U.S.

According to the American Cancer Society, 1,688,780 new cases of cancer were diagnosed in U.S. in 2017. Clinical tests are made as one of the major diagnostic tools is expected to augment market growth in future. Sudden outbreaks of Ebola, Zika, and other contagious diseases are also contributing to rising prevalence of infectious diseases.

Product Insights

Reagents accounted for the global revenue share in the clinical microbiology market. This segment includes products such as solutions, primers, master mixes, and kits used in various diagnostic assays. Reagents currently takes the largest revenue share, with more than 60% attributed to repeat purchase driven by need for new set of reagents for new tests.

This segment is expected to remain dominant throughout the forecast period. Factors such as higher cost of specialized kits and constant repeat purchase are expected to drive the segment over the forecast period. The market is witnessing rising investments in research and development (R&D). Almost all analytical and therapeutic research projects demand reagents and chemicals, thereby driving penetration of reagents.

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!